Stage II Follicular Thyroid Cancer
3 clinical trials · Condition
◉ Watch Stage II Follicular Thyroid Cancer
| Record | Firm | Date |
|---|---|---|
| Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer (NCT00470496) | Roswell Park Cancer Institute | 2006-10-19 |
| Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer (NCT00134043) | National Cancer Institute (NCI) | 2005-12-01 |
| Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy (NCT00104871) | National Cancer Institute (NCI) | 2004-12-01 |
Track Stage II Follicular Thyroid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.